Free Trial

BioNexus Gene Lab (BGLC) Short Interest Ratio & Short Volume

BioNexus Gene Lab logo
$0.38
+0.02 (+5.60%)
(As of 11/1/2024 ET)

BioNexus Gene Lab Short Interest Data

BioNexus Gene Lab (BGLC) has a short interest of 101,600 shares, representing 0.87% of the float (the number of shares available for trading by the public). This marks a -45.14% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 629,476 shares to cover all short positions.

Current Short Interest
101,600 shares
Previous Short Interest
185,200 shares
Change Vs. Previous Month
-45.14%
Dollar Volume Sold Short
$39,522.40
Short Interest Ratio
0.3 Days to Cover
Last Record Date
October 15, 2024
Outstanding Shares
17,968,000 shares
Float Size
11,710,000 shares
Short Percent of Float
0.87%
Today's Trading Volume
58,045 shares
Average Trading Volume
629,476 shares
Today's Volume Vs. Average
9%
Short Selling BioNexus Gene Lab?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for BioNexus Gene Lab and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

BGLC Short Interest Over Time

BGLC Days to Cover Over Time

BGLC Percentage of Float Shorted Over Time

BioNexus Gene Lab Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/15/2024101,600 shares $39,522.40 -45.1%0.9%0.3 $0.39
9/30/2024185,200 shares $82,414.00 -78.3%1.6%0.5 $0.45
9/15/2024852,200 shares $340,880.00 +670.5%7.3%2.3 $0.40
8/31/2024110,600 shares $48,752.48 +7.3%1.4%0.8 $0.44
8/15/2024103,100 shares $46,364.07 -10.5%1.3%0.7 $0.45
7/31/2024115,200 shares $56,183.04 -48.8%1.5%0.7 $0.49
7/15/2024224,800 shares $119,233.92 +19.0%2.9%1.4 $0.53
6/30/2024188,900 shares $89,765.28 +6.2%2.4%0.9 $0.48
6/15/2024177,900 shares $78,631.80 +204.1%2.3%0.8 $0.44
5/31/202458,500 shares $24,850.80 -44.8%0.7%0.3 $0.42
5/15/2024105,900 shares $61,432.59 -40.0%1.3%0.5 $0.58
4/30/2024176,500 shares $109,412.35 +77.0%2.5%0.1 $0.62
4/15/202499,700 shares $61,983.49 +129.7%1.4%0.1 $0.62
3/31/202443,400 shares $30,640.40 +115.9%0.6%0 $0.71
3/15/202420,100 shares $14,381.55 -60.0%0.3%0 $0.72
2/29/202450,300 shares $28,268.60 -94.6%0.7%0 $0.56
2/15/2024922,200 shares $1.05 million +885.3%12.1%0.3 $1.14
1/31/202493,600 shares $43,926.48 No Change1.2%0 $0.47
7/15/202320,600 shares $22,248.00 +4,020.0%N/A0 $1.08

BGLC Short Interest - Frequently Asked Questions

What is BioNexus Gene Lab's current short interest?

Short interest is the volume of BioNexus Gene Lab shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 101,600 shares of BGLC short. 0.87% of BioNexus Gene Lab's shares are currently sold short. Learn More on BioNexus Gene Lab's current short interest.

What is a good short interest percentage for BioNexus Gene Lab?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.87% of BioNexus Gene Lab's floating shares are currently sold short.

Is BioNexus Gene Lab's short interest increasing or decreasing?

BioNexus Gene Lab saw a decline in short interest in October. As of October 15th, there was short interest totaling 101,600 shares, a decline of 45.1% from the previous total of 185,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is BioNexus Gene Lab's float size?

BioNexus Gene Lab currently has issued a total of 17,968,000 shares. Some of BioNexus Gene Lab's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BioNexus Gene Lab currently has a public float of 11,710,000 shares.

How does BioNexus Gene Lab's short interest compare to its competitors?

0.87% of BioNexus Gene Lab's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to BioNexus Gene Lab: ATI Physical Therapy, Inc. (0.77%), The Oncology Institute, Inc. (0.76%), Renalytix Plc (0.46%), Psychemedics Co. (0.55%), BioRestorative Therapies, Inc. (0.91%), Marpai, Inc. (0.22%), Centogene (0.69%), Ontrak, Inc. (8.33%), Vsee Health, Inc. (0.83%), CareMax, Inc. (5.24%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

What does it mean to sell short BioNexus Gene Lab stock?

Short selling BGLC is an investing strategy that aims to generate trading profit from BioNexus Gene Lab as its price is falling. BGLC shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against BioNexus Gene Lab?

A short squeeze for BioNexus Gene Lab occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BGLC, which in turn drives the price of the stock up even further.

How often is BioNexus Gene Lab's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BGLC, twice per month. The most recent reporting period available is October, 15 2024.




This page (NASDAQ:BGLC) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners